Jyothy Laboratories Ltd. said its normalized net income for the fiscal fourth quarter ended March 31 amounted to 85 Indian paise per share, compared with the S&P Capital IQ consensus estimate of 2.35 rupees per share.
EPS climbed 69.2% year over year from 50 paise.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 155.9 million rupees, a gain of 71.0% from 91.2 million rupees in the year-earlier period.
The normalized profit margin climbed to 3.9% from 2.6% in the year-earlier period.
Total revenue climbed 11.3% on an annual basis to 3.96 billion rupees from 3.56 billion rupees, and total operating expenses grew 9.4% from the prior-year period to 3.65 billion rupees from 3.34 billion rupees.
Reported net income increased 26.0% on an annual basis to 271.3 million rupees, or 1.48 rupees per share, from 215.3 million rupees, or 1.19 rupees per share.
For the year, the company's normalized net income totaled 4.09 rupees per share, compared with the S&P Capital IQ consensus normalized EPS estimate of 6.87 rupees.
EPS rose 41.5% from 2.89 rupees in the prior year.
Normalized net income was 744.5 million rupees, an increase of 50.9% from 493.4 million rupees in the prior year.
Full-year total revenue rose 14.2% year over year to 15.06 billion rupees from 13.19 billion rupees, and total operating expenses grew 15.9% on an annual basis to 13.77 billion rupees from 11.89 billion rupees.
The company said reported net income rose 48.7% year over year to 1.21 billion rupees, or 6.65 rupees per share, in the full year, from 815.1 million rupees, or 4.77 rupees per share.
As of July 6, US$1 was equivalent to 63.30 Indian rupees.